RecruitingPhase 3NCT06763328
Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Sponsor: City of Hope Medical Center
Duarte, CA · La Jolla, CA · Riverside, CA
Ensayos clínicos de cáncer de mama
368 estudios buscan participantes en EE. UU.
La mayoría de los estudios de cáncer de mama son ensayos de tratamiento de fase 2, a menudo definidos por el tipo de tumor: con receptores hormonales positivos, HER2 positivo o triple negativo. La elegibilidad suele depender de la etapa, los tratamientos previos y los estudios de imagen recientes, por lo que conviene tener a mano su informe de patología. También hay muchos estudios para sobrevivientes sobre ejercicio, alimentación y efectos secundarios, que suelen tener requisitos más sencillos.
Mostrando 40 de 368 estudios (en inglés)
RecruitingPhase not listedNCT00034216
Collection of Blood From Patients With Cancer
Sponsor: National Cancer Institute (NCI)
Bethesda, MD
RecruitingPhase not listedNCT00451022
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Sponsor: National Cancer Institute (NCI)
Bethesda, MD
RecruitingPhase 2NCT01174121
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Sponsor: National Cancer Institute (NCI)
Bethesda, MD
RecruitingPhase 1NCT04222413
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Bethesda, MD
RecruitingPhase 1NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Sponsor: Eli Lilly and Company
Duarte, CA · La Jolla, CA · Los Angeles, CA · +20 more sites
RecruitingPhase 1NCT07137416
Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
Sponsor: National Cancer Institute (NCI)
Boston, MA · St Louis, MO
RecruitingPhase 3NCT07391774
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Sponsor: National Cancer Institute (NCI)
Jonesboro, AR · Auburn, CA · Berkeley, CA · +200 more sites
RecruitingNot applicableNCT07501637
Mind-Body Group Interventions for Psychological Distress in Young Breast Cancer Survivors
Sponsor: University of Alabama at Birmingham
Birmingham, AL
RecruitingPhase 1NCT06120283
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Sponsor: BeOne Medicines
Denver, CO · Lake Mary, FL · Detroit, MI · +6 more sites
RecruitingPhase 1NCT06545331
Study of XB010 in Subjects With Solid Tumors
Sponsor: Exelixis
Irvine, CA · Los Angeles, CA · Washington D.C., DC · +13 more sites
RecruitingPhase 1NCT05111561
Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer
Sponsor: National Cancer Institute (NCI)
Boston, MA · Galveston, TX · +1 more sites
RecruitingPhase not listedNCT07616856
Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry
Sponsor: Lumicell, Inc.
Palo Alto, CA
RecruitingPhase not listedNCT05056857
Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen
Sponsor: M.D. Anderson Cancer Center
Houston, TX
RecruitingEarly Phase 1NCT06008275
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
Sponsor: Baylor Research Institute
Dallas, TX
RecruitingPhase 2NCT06049355
EMBRACE: Exercising Together
Sponsor: OHSU Knight Cancer Institute
Portland, OR
RecruitingPhase 3NCT06841354
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
Sponsor: Merck Sharp & Dohme LLC
Mobile, AL · Chandler, AZ · Duarte, CA · +36 more sites
RecruitingPhase 1NCT07310420
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Sponsor: TerSera Therapeutics LLC
Hot Springs, AR · Washington D.C., DC · Ocoee, FL · +23 more sites
RecruitingPhase 2NCT06749210
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
Sponsor: Ohio State University Comprehensive Cancer Center
New Haven, CT · Columbus, OH
RecruitingPhase 1NCT07261631
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Sponsor: Novartis Pharmaceuticals
Princeton, NJ
RecruitingPhase 2NCT05676255
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
Sponsor: University of Arizona
Tucson, AZ
RecruitingPhase 3NCT07174336
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sponsor: Eli Lilly and Company
Anchorage, AK · Chandler, AZ · Phoenix, AZ · +126 more sites
RecruitingPhase 1NCT07311993
Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
Sponsor: Cellectar Biosciences, Inc.
Jacksonville, FL · Glen Burnie, MD · Rochester, MN · +1 more sites
RecruitingPhase 1 / Phase 2NCT05579366
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor: Genmab
Phoenix, AZ · Tucson, AZ · Los Angeles, CA · +34 more sites
RecruitingPhase 1NCT07114601
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Sponsor: Eli Lilly and Company
Duarte, CA · Santa Monica, CA · Stanford, CA · +13 more sites
RecruitingPhase not listedNCT00477100
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Gilbert, AZ · La Jolla, CA · Greeley, CO · +7 more sites
RecruitingPhase not listedNCT05056818
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
Sponsor: M.D. Anderson Cancer Center
Houston, TX
RecruitingPhase 3NCT05774678
Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Tissue Nanomechanical Phenotype Evaluation
Sponsor: M.D. Anderson Cancer Center
Houston, TX
RecruitingPhase 1NCT06545682
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
Sponsor: M.D. Anderson Cancer Center
Houston, TX
RecruitingPhase 3NCT06790693
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Sponsor: Hoffmann-La Roche
Goodyear, AZ · Phoenix, AZ · Burbank, CA · +59 more sites
RecruitingPhase 2NCT07405801
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
Sponsor: Hoffmann-La Roche
Anaheim, CA · Palo Alto, CA · Jacksonville, FL · +7 more sites
RecruitingPhase 2NCT02422641
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Sponsor: Wake Forest University Health Sciences
Baltimore, MD · St Louis, MO · Winston-Salem, NC
RecruitingNot applicableNCT06037954
A Study of Mental Health Care in People With Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
New York, NY
RecruitingPhase 1NCT06840886
A Study of PHST001 in Advanced Solid Tumors
Sponsor: Pheast Therapeutics
Beverly Hills, CA · Los Angeles, CA · Palo Alto, CA · +17 more sites
RecruitingPhase 3NCT06982521
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Sponsor: Relay Therapeutics, Inc.
Gilbert, AZ · Beverly Hills, CA · Duarte, CA · +49 more sites
RecruitingPhase 1NCT07454642
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Sponsor: Avacta Life Sciences Ltd
Scottsdale, AZ · Sarasota, FL · Chicago, IL · +4 more sites
RecruitingPhase 2NCT06153836
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction
Sponsor: Mayo Clinic
Jacksonville, FL
RecruitingPhase 1NCT06270706
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Sponsor: Pliant Therapeutics, Inc.
New Haven, CT · Atlanta, GA · Grand Rapids, MI · +13 more sites
RecruitingPhase 2NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Sponsor: Bayer
Birmingham, AL · Duarte, CA · Fort Myers, FL · +8 more sites
RecruitingNot applicableNCT07059884
Distance-Based Exercise to Preserve Function and Prevent Disability
Sponsor: Alliance for Clinical Trials in Oncology
Dublin, CA · Fremont, CA · Fresno, CA · +20 more sites
La información proviene de ClinicalTrials.gov y es solo informativa; no es consejo médico. Confirme siempre su elegibilidad con el equipo del estudio y hable con su médico antes de tomar decisiones sobre su atención.